Skip to main content
Glama

archive

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the read-only/idempotent annotations, the description discloses meaningful behavior: it cascades through multiple lookup endpoints, degrades gracefully when GLEIF or OpenFIGI is unavailable, labels identifier sources, and exposes unresolved identifiers explicitly under `unresolved`. This substantially exceeds what the annotations alone convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with examples and a priority rule, and the content is organized around supported types and edge cases. Some sentences are overwrought and could be tightened, but the structure is logical and every major section earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description effectively carries the burden of explaining return content: for company it lists CIK, ticker, company_name, LEI, and FIGI; for drug it lists RxCUI, ingredient, and brand. It also covers failure modes like unresolved identifiers, ambiguous matches, and enrichment unavailability, making the tool fully self-contained for correct invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description adds significant meaning: it defines accepted input forms (ticker, CIK, ISIN, name), explains ISIN-to-LEI resolution, describes how type affects behavior, and warns that trailing security-class words should be omitted. This goes well beyond the schema's field names and basic descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the verb and resource: it resolves user-spoken names to canonical/official identifiers. The examples and 'Use FIRST whenever you have a name but need an ID' make the tool's role unmistakable and distinguish it from sibling tools focused on search, profiles, or comparisons.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit when-to-use rule: 'Use FIRST whenever you have a name but need an ID.' It also explains ambiguous-name behavior and when `figi_candidates` is returned, but it does not explicitly name sibling alternatives or state when not to use this tool, so it falls just short of full routing guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All archive toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

The ask_pipeworx family (ask_pipeworx / ask_pipeworx_beta / ask_pipeworx_grounded / deep_research) has significant boundary blurring—ask_pipeworx_beta explicitly 'currently matches ask_pipeworx exactly'—and the six prediction-market tools (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) have heavily overlapping edge-detection purposes. Only the archive, memory, and subscription families are cleanly delineated.

Naming Consistency3/5

There are consistent family prefixes (ask_*, polymarket_*, pipeworx_*) and clean pluralized lists (list_files, list_subscriptions), but the full set mixes bare verbs (remember, recall, forget, search), nouns (entity_profile), and varying patterns (bet_research vs compare_entities, search vs search_within vs recent_changes). Readable in clusters, but no single naming convention binds the set.

Tool Count2/5

35 tools is heavy, and the count is fattened by five distinct product areas—data routing, prediction markets, archive.org access, memory, and subscriptions—that have little to do with each other or with the server name 'archive'. It sits in the 25+ heavy zone even before honoring the mismatch between its name and the sprawl of its purpose.

Completeness3/5

Individual subdomains are well-covered: the memory trio (remember/recall/forget), subscription lifecycle (subscribe/unsubscribe/list_subscriptions/recent_alerts), and archive lineup (search/get_metadata/list_files/wayback_check) are each complete, and extra machinery like pipeworx_feedback and recent_changes shows domain care. But the unifying domain is incoherent—a server named 'archive' that's also a universal data router and prediction-market toolkit—and the scope ends up both bloated and still full of gaps for any one of the intended users (e.g. no archive-item upload, no prediction-market portfolio management).

Resources